| Review Article Online Published: 10 Apr 2026 | ||||||||||||
IJMDC. 2026; 10(5): 1436-1448 Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review Horiah Amer Al-ghorbany, Teef Saleh Althobaiti, Lama Meerkhan, Farah Hassan Althobaiti, Reem Shubayr, Renad Mohammed Alhusayni, Raghid Alahmadi, Anwar Shams.
| ||||||||||||
| How to Cite this Article |
| Pubmed Style Al-ghorbany HA, Althobaiti TS, Meerkhan L, Althobaiti FH, Shubayr R, Alhusayni RM, Alahmadi R, Shams A. Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review. IJMDC. 2026; 10(5): 1436-1448. doi:10.24911/IJMDC.51-1770907382 Web Style Al-ghorbany HA, Althobaiti TS, Meerkhan L, Althobaiti FH, Shubayr R, Alhusayni RM, Alahmadi R, Shams A. Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review. https://www.ijmdc.com/?mno=310288 [Access: May 07, 2026]. doi:10.24911/IJMDC.51-1770907382 AMA (American Medical Association) Style Al-ghorbany HA, Althobaiti TS, Meerkhan L, Althobaiti FH, Shubayr R, Alhusayni RM, Alahmadi R, Shams A. Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review. IJMDC. 2026; 10(5): 1436-1448. doi:10.24911/IJMDC.51-1770907382 Vancouver/ICMJE Style Al-ghorbany HA, Althobaiti TS, Meerkhan L, Althobaiti FH, Shubayr R, Alhusayni RM, Alahmadi R, Shams A. Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review. IJMDC. (2026), [cited May 07, 2026]; 10(5): 1436-1448. doi:10.24911/IJMDC.51-1770907382 Harvard Style Al-ghorbany, H. A., Althobaiti, . T. S., Meerkhan, . L., Althobaiti, . F. H., Shubayr, . R., Alhusayni, . R. M., Alahmadi, . R. & Shams, . A. (2026) Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review. IJMDC, 10 (5), 1436-1448. doi:10.24911/IJMDC.51-1770907382 Turabian Style Al-ghorbany, Horiah Amer, Teef Saleh Althobaiti, Lama Meerkhan, Farah Hassan Althobaiti, Reem Shubayr, Renad Mohammed Alhusayni, Raghid Alahmadi, and Anwar Shams. 2026. Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review. International Journal of Medicine in Developing Countries, 10 (5), 1436-1448. doi:10.24911/IJMDC.51-1770907382 Chicago Style Al-ghorbany, Horiah Amer, Teef Saleh Althobaiti, Lama Meerkhan, Farah Hassan Althobaiti, Reem Shubayr, Renad Mohammed Alhusayni, Raghid Alahmadi, and Anwar Shams. "Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review." International Journal of Medicine in Developing Countries 10 (2026), 1436-1448. doi:10.24911/IJMDC.51-1770907382 MLA (The Modern Language Association) Style Al-ghorbany, Horiah Amer, Teef Saleh Althobaiti, Lama Meerkhan, Farah Hassan Althobaiti, Reem Shubayr, Renad Mohammed Alhusayni, Raghid Alahmadi, and Anwar Shams. "Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review." International Journal of Medicine in Developing Countries 10.5 (2026), 1436-1448. Print. doi:10.24911/IJMDC.51-1770907382 APA (American Psychological Association) Style Al-ghorbany, H. A., Althobaiti, . T. S., Meerkhan, . L., Althobaiti, . F. H., Shubayr, . R., Alhusayni, . R. M., Alahmadi, . R. & Shams, . A. (2026) Efficacy and safety of sirolimus in the treatment of patients with lymphangioleiomyomatosis: a systematic review. International Journal of Medicine in Developing Countries, 10 (5), 1436-1448. doi:10.24911/IJMDC.51-1770907382 |